Phase
Condition
Colorectal Cancer
Carcinoma
Cancer
Treatment
Pembrolizumab
BBO-8520
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Histologically documented locally advanced and unresectable or metastatic non-smallcell lung cancer with a KRAS G12C mutation
Measurable disease by RECIST v1.1
Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
Exclusion
Exclusion Criteria:
Patients with malignancy within the last 2 years as specified in the protocol
Patients with untreated brain metastases
Patients with known hypersensitivity to BBO-8520 or its excipients
For Cohorts 1b and 2b:
Patients with a known hypersensitivity to pembrolizumab or its excipients
Patients with active autoimmune disease of history of autoimmune disease that mightrecur
Patients with a history of interstitial lung disease/pneumonitis that requiredsteroids, or current interstitial lung disease/pneumonitis
Other inclusion/exclusion criteria may apply
Study Design
Study Description
Connect with a study center
Kinghorn Cancer Centre
Darlinghurst, New South Wales 2010
AustraliaActive - Recruiting
Flinders Medical Centre
Bedford Park, South Australia 5042
AustraliaActive - Recruiting
The Queen Elizabeth Hospital
Woodville South, South Australia 5011
AustraliaActive - Recruiting
Peninsula & South Eastern Hematology and Oncology Group (PAS)
Frankston, Victoria 3199
AustraliaActive - Recruiting
Peter MacCallum Cancer Centre
Melbourne, Victoria 3051
AustraliaActive - Recruiting
University of California - San Diego Moores Cancer Center
La Jolla, California 92093
United StatesActive - Recruiting
UCLA Health - Santa Monica Cancer Care
Santa Monica, California 90404
United StatesActive - Recruiting
Yale Cancer Center
New Haven, Connecticut 06510
United StatesActive - Recruiting
Norwalk Hospital
Norwalk, Connecticut 06850
United StatesActive - Recruiting
University of Kansas Medical Center
Kansas City, Kansas 66205
United StatesActive - Recruiting
Cleveland Clinic
Cleveland, Ohio 44195
United StatesActive - Recruiting
SCRI Oncology Partners
Nashville, Tennessee 37203
United StatesActive - Recruiting
Huntsman Cancer Institute
Salt Lake City, Utah 84112
United StatesActive - Recruiting
NEXT Oncology
Fairfax, Virginia 22031
United StatesActive - Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington 98109
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.